Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway

Toxicology Letters

Volumn 98, Issue 1-2, 1998, Pages 13-23

  Edgar, Alan D ^a   Tomkiewicz, Céline ^b   Costet, Philippe ^c   Legendre, Christiane ^a   Aggerbeck, Martine ^b   Bouguet, Jacqueline ^b   Staels, Bart ^d   Guyomard, Claire ^e   Pineau, Thierry ^c   Barouki, Robert ^b  

^a Laboratoires Fournier SA   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c CEMAGREF   (France)

^d INSERM   (France)

^e BIOPREDIC   (France)

Author keywords

Fibrates; Peroxisome proliferator activated receptor; Transaminases

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FENOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FATTY ACID METABOLISM; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; LIVER INJURY; LIVER TOXICITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; ANTILIPEMIC AGENTS; ASPARTATE AMINOTRANSFERASES; BLOTTING, NORTHERN; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIVER; MICE; NUCLEAR PROTEINS; PROCETOFEN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSAMINASES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0032169919     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00042-3     Document Type: Article

References (47)

1. Aggerbeck M., Garlatti M., Feilleux-Duché S., Veyssier C., Daheshia M., Hanoune J., Barouki R. Regulation of the cytosolic aspartate aminotransferase housekeeping gene promoter by glucocorticoids, cAMP, and Insulin. Biochemistry. 32:1993;9065-9072.
2. Balfour J.A., McTavish D., Heel R.C. Fenofibrate, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidemia. Drugs. 40:1990;260-290.
3. Barouki R., Pavé-Preux M., Bousquet-Lemercier B., Pol S., Bouguet J., Hanoune J. Regulation of cytosolic aspartate aminotransferase mRNAs in the Fao rat hepatoma cell line by dexamethasone, insulin and cyclic AMP. Eur. J. Biochem. 186:1989;79-85.
4. Bennett M.K., Lopez J.M., Sanchez H.B., Osborne T.F. Sterol regulation of fatty acid synthase promoter: Coordinate feedback regulation of two major lipid pathways. J. Biol. Chem. 270:1995;25578-25583.
5. Berkowitz D. Effects of chlorophenoxyisobutyrate with and without androsterone on the serum lipids, fat tolerance and uric acid. Metabolism. 14:1965;966-975.
6. Berthou L., Duverger N., Emmanuel F., Langouet S., Auwerx J., Guillouzo A., Fruchart J.-C., Rubin E., Denefle P., Staels B., Branellec D. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. J. Clin. Invest. 97:1996;2408-2416.
7. Bousquet-Lemercier B., Pol S., Pavé-Preux M., Hanoune J., Barouki R. Properties of human liver cytosolic aspartate aminotransferase mRNAs generated by alternative polyadenylation site selection. Biochemistry. 29:1990;5293-5299.
8. Brown W.V., Dujovne C.A., Farquhar J.W., Feldman E.B., Grundy S.M., Knopp R.H., Lasser N.L., Mellies M.J., Palmer R.H., Samuel P., Schonfeld G., Superko H.R. Effects of fenofibrate on plasma lipids; Double blind, multicentered study in patients with type IIa or IIb hyperlipidemia. Arteriosclerosis. 6:1986;670-678.
9. Carlisle T.L., Roncero C., El Khadir-Mounier C., Thurmond D.C., Goodridge A.G. Malic enzyme gene in chick embryo hepatocytes in culture: clofibrate regulates responsiveness to triiodothyronine. J. Lipid Res. 37:1996;2088-2097.
10. Chirgwin J.M., Przyblya A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
11. Cooper, A.J.L., Meister, A., 1985. Metabolic significance of transamination. In: Christen, P., Metzler, D.E. (Eds.), Transaminases, New York, Wiley, pp. 534-563.
12. Day A.P., Feher M.D., Chopra R., Mayne P.D. The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities. Metabolism. 42:1993;839-842.
13. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68:1992;879-887.
14. Feilleux-Duché S., Garlatti M., Aggerbeck M., Bouguet J., Hanoune J., Barouki R. Phorbol esters inhibit the glucocorticoid-mediated stimulation of cytosolic aspartate aminotransferase gene transcription. Biochem. J. 297:1994;497-502.
15. Garlatti M., Tchesnokov V., Daheshia M., Feilleux-Duché S., Hanoune J., Aggerbeck M., Barouki R. CCAAT/Enhancer-binding protein-related proteins bind to the unusual promoter of the aspartate aminotransferase housekeeping gene. J. Biol. Chem. 268:1993;6567-6574.
16. Gebel T., Arand M., Oesch F. Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver. FEBS Lett. 309:1992;37-40.
17. Gugen-Guillouzo, C., Guillouzo, A., 1986. Methods for preparation of adult and fetal hepatocytes. In: Guillouzo, A., Gugen-Guillouzo, C. (Eds.), Isolated and Cultured Hepatocytes, Les Editions INSERM and John Libby Eurotext, pp. 1-12.
18. Hertz R., Nikodem V., Ben-Ishai A., Berman I., Bar-Tana J. Thyromimetic mode of action of peroxisome proliferators: activation of 'malic' enzyme gene transcription. Biochem. J. 319:1996;241-248.
19. Herzfeld A., Greengard O. Aspartate aminotransferase in fat tissues: changes with growth and hormones. Biochim. Biophys. Acta. 237:1971;88-98.
20. Horio Y., Tanaka T., Taketoshi M., Uno T., Wada H. Rat cytosolic aspartate aminotransferase: regulation of its mRNA and contribution to gluconeogenesis. J. Biochem. 103:1988;805-808.
21. Ishiguro M., Takio K., Suzuki M., Oyama R., Matsuzawa T., Titani K. Complete amino acid sequence of human liver cytosolic alanine aminotransferase (GPT) determined by a combination of conventional and mass spectral methods. Biochemistry. 30:1991;10451-10457.
22. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
23. Katunuma N., Okada M., Nishi Y. Regulation of the urea cycle and TCA cycle by ammonia. Adv. Enzyme Reg. 4:1966;317-335.
24. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2160-2164.
25. Knowles B.B., Howe C.C., Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 209:1980;497-499.
26. Lee S.S.-T., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., Gonzalez F. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:1995;3012-3022.
27. Lennon G., Auffray C., Polymeropoulos M., Soares M.B. The IMAGE Consortium: an integrated molecular analysis of genomes and their expression. Genomics. 33:1996;151-152.
28. Lopez J.M., Bennett M.K., Sanchez H.B., Osborne T.F. Sterol regulation of acetyl coenzyme A carboxylase: A mechanism for coordinate control of cellular lipid. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1049-1053.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. Obaru K., Tsuzuki T., Setoyama C., Shimada K. Structural organization of the mouse aspartate aminotransferase isoenzyme genes. Introns antedate the divergence of cytosolic and mitochondrial isoenzyme genes. J. Mol. Biol. 200:1988;13-22.
31. Oliver M.F. Further observations on the effect of Atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levels. J. Atherosc. Res. 3:1963;427-444.
32. Parli J.A., Godfrey D.A., Ross C.D. Separate enzymatic microassays for aspartate aminotransferase isoenzymes. Biochim. Biophys. Acta. 925:1987;175-184.
33. Pavé-Preux M., Aggerbeck M., Veyssier C., Bousquet-Lemercier B., Hanoune J., Barouki R. Hormonal discrimination among transcription start sites of aspartate aminotransferase. J. Biol. Chem. 265:1990;4444-4448.
34. Pol S., Nalpas B., Vassault A., Bousquet-Lemercier B., Franco D., Lacour B., Berthelot P., Hanoune J., Barouki R. Hepatic activity and mRNA expression of aspartate aminotransferase isoenzymes in alcoholic and nonalcoholic liver disease. Hepatology. 14:1991;620-625.
35. Reddy J.K., Goel S.K., Nemali M.R., Carrino J.J., Laffler T.G., Reddy M.K., Sperbeck S.J., Osumi T., Hashimoto T., Lalwani N.D., Rao M.S. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. U.S.A. 83:1986;1747-1751.
36. Schmidt, E., Schmidt, F.W., 1985. Aminotransferases in human pathology and clinical chemistry. In: Christen P., Metzler, D.E. (Eds.) Transaminases, Wiley, New York, pp. 587-624.
37. Schoonjans K., Staels B., Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:1996;907-925.
38. Setoyama C., Ding S.H., Choudhury B.K., Joh T., Takeshima H., Tsuzuki T., Shimada K. Regulatory regions of the mitochondrial and cytosolic isoenzyme genes participating in the malate-aspartate shuttle. J. Biol. Chem. 265:1990;1293-1299.
39. Shalev A., Siegrist-Kaiser C.A., Yen P.M., Wahli W., Burger A.G., Chin W.W., Meier C.A. The peroxisome proliferator-activated receptor α is a phosphoprotein: regulation by insulin. Endocrinology. 137:1996;4499-4502.
40. Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S., Goldstein J.L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98:1996;1575-1584.
41. Sonderegger, P., Jaussi, R., Christen, P., 1985. Genetics, biosynthesis and intracellular processing of aspartate aminotransferase isoenzymes. In: Christen, P., Metzler, D.E. (Eds), Transaminases, Wiley, New York, pp. 501-510.
42. Staels B., Van Tol A., Andreu T., Auwerx J. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue selective manner. Arterioscler. Thromb. 12:1992;286-294.
43. Staels B., Vu-Dac N., Kosykh V.A., Saladin R., Fruchart J.-C., Dallongeville J., Auwerx J. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl Coenzyme A oxidase. J. Clin. Invest. 95:1995;705-712.
44. Steineger H.H., Sorensen H.N., Tugwood J.D., Skrede S., Spydevold O., Gautvik K.M. Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty-acid-induced transcription. Eur. J. Biochem. 225:1994;967-974.
45. Tugwood J.D., Issemann I., Anderson R.G., Bundell K.R., McPheat W.L., Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:1992;433-439.
46. Vu-Dac N., Schoonjans K., Laine B., Fruchart J.-C., Auwerx J., Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J. Biol. Chem. 269:1994;31012-31018.
47. Vu-Dac N., Schoonjans K., Kosykh V., Dallongeville J., Fruchart J.-C., Staels B., Auwerx J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96:1995;741-750.